oncosphere	Other
EgKI-1-treated_mice	Species
cancer_cells	Disease
significant_tumor_growth_reduction	Disease
tumor_growth_reduction_in_mice	Disease	Species
normal_cell_growth	Other
dose-dependent_manner	Other
cancer_cell_growth	Disease
tumor_growth_reduction_in_EgKI-1-treated_mice	Disease	Species
normal_cell_growth	Other
cell_growth	Other
tumor_growth_reduction	Disease
anti-cancer_therapeutic	Other
oncosphere_of_canine_tapeworm_Echinococcus	Species
oncosphere	Other
promise_for_future_development	Other
cancer_cell_growth	Disease
significant_tumor_growth_reduction_in_EgKI-1-treated_mice	Disease	Species
cancer_cells	Disease
cell_cycle	Other
oncosphere_of_tapeworm_Echinococcus	Other
tumor_growth_reduction	Disease
oncosphere_of_canine_tapeworm_Echinococcus	Species
oncosphere_of_tapeworm_Echinococcus	Other
cell_apoptosis	Other
cell_proliferation	Other
additive_manner	Other
tamoxifen	Chemical
tamoxifen	Chemical
cell_migration	Other
ER_cancer	Gene	Disease
transcription	Other
G2/M_phase	Other
cell_migration	Other
cell_cycle	Other
single_tamoxifen	Chemical
tamoxifen	Chemical
co-treatment_of_tamoxifen	Chemical
cell_growth_at_higher_concentrations	Other
co-treatment	Other
ER_cancer	Gene	Disease
death	Disease
ER_cancer	Gene	Disease
ERÎ±66	Other
cell_migration	Other
ER_cancer	Gene	Disease
transcription_of_cell_cycle_regulation_proteins	Other
cell_growth_at_concentrations	Other
co-treatment_of_tamoxifen	Chemical
expression_of_mitochondrial_apoptotic_proteins	Other
transcription_of_cell_cycle_regulation_proteins	Other
cell_growth	Other
G2/M_phase	Other
tamoxifen	Chemical
cell_growth_of_MCF-7_cells_at_higher_concentrations	Other
cell_cycle	Other
co-treatment	Other
cell_migration	Other
4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
patient	Species
vary_on_voxel-basis	Other
information_of_breast_resulting_in_detection_diagnosis_of_breast_cancer	Disease
phantom	Other
enhancement_dynamics	Other
perfusion_in_different_types_of_breast_lesions	Other
breast_CT_image	Other
vary_on_voxel-basis	Other
vary	Other
voxel	Other
patient	Species
different_types_of_breast_lesions	Other
work	Other
healthy_patient_into_skin_fibroglandular_tissue_adipose_tissue	Species
voxel-basis	Other
different_enhancement_dynamics	Other
functional_information	Other
example	Other
voxel-basis	Other
voxel-basis	Other
perfusion_parameters	Other
4D_breast_CT_image_acquisition	Other
example	Other
functional_information_of_breast_resulting_in_detection_diagnosis_of_breast_cancer_with_breast_CT.	Disease
information_of_breast_resulting	Other
healthy_patient_into_skin_fibroglandular_tissue_adipose_tissue	Species
breast	Other
breast_CT.	Other
vary	Other
voxel-basis	Other
expected_enhancement_of_tissues_consistent_with_given_input_parameters	Other
breast_tissue_perfusion	Other
voxel-basis	Other
vary_on_voxel-basis	Other
voxel	Other
perfusion_parameters	Other
information_of_breast	Other
information_of_breast_resulting_in_detection_diagnosis_with_breast_CT.	Other
voxel	Other
breast_tissue_perfusion	Other
perfusion_parameters	Other
voxel	Other
information_of_breast_resulting_in_detection_diagnosis	Other
breast_tissue_perfusion	Other
voxel-basis	Other
perfusion_parameters_associated_with_tissue_voxel	Other
information_of_breast_resulting_in_detection_diagnosis_of_breast_cancer_with_breast_CT.	Disease
enhancement_dynamics	Other
breast_tissue_perfusion	Other
information	Other
convolution_between_arterial_input_function	Other
cell_lines	Other
increasing_OPAE_concentration	Other
potent_activity_in_in-vitro_models	Other
antioxidant_free-radical_scavenging_against_human_breast-cancer_cell_lines	Species	Disease
activity_in_in-vitro_models	Other
increasing_OPAE_concentration_up_to_240_g/mL	Other
potent_activity_in_in-vitro_models	Other
human_cell_lines	Species
human_breast-cancer_cell_lines	Species	Disease
human_cell_lines	Species
increasing_OPAE_concentration	Other
potent_activity	Other
OPAE_concentration_up_to_240_g/mL	Other
activity	Other
OPAE_concentration	Other
anticancer_activities_of_O._pallidus	Other
OPAE_concentration_up_to_240_g/mL	Other
free-radical_scavenging_against_human_breast-cancer_cell_lines	Species	Disease
human_breast-cancer_cell_lines	Species	Disease
power_activities	Other
in-vitro_models	Other
free-radical_scavenging	Other
increasing_OPAE_concentration_up_to_240_g/mL	Other
activity_in_models	Other
OPAE_concentration	Other
cell_lines	Other
potent_activity_in_models	Other
women_with_BCs_treated_from_2008_to_2017	Species
women_with_HER2-positive_BCs_treated_with_trastuzumab_from_2008_to_2017	Species
group_AB	Other
nAB_regimen	Other
women	Species
women_with_HER2-positive_BCs_treated_with_trastuzumab	Species
two_groups_including_196_patients	Species
human_epidermal_growth_factor_receptor_2	Species
nAB_regimen	Other
women	Species
HER2-positive_BCs_treated_from_2008_to_2017	Other
nAB_regimen	Other
nAB_regimen	Other
prognosis_discussion_communication_skills	Other
advanced_breast_cancer	Disease
advanced_breast_cancer	Disease
appointment	Other
intervention_easy	Other
intervention_feasibility	Other
intervention	Other
T-PAT_appointment	Disease
advanced_breast_cancer	Disease
breast_cancer	Disease
realistic_beliefs_about_disease_curability	Other
planned_prognosis_discussion	Other
appointment	Other
utilization_of_acid_for_breast_cancer_therapy	Disease
aldehyde_dehydrogenase	Chemical
utilization_for_breast_cancer_therapy_via_disruption	Disease
isolation_of_one_compound	Other
CD44high/CD24low_subpopulation	Other
dose-dependent_manner	Other
cancer_prevention	Disease
isolation	Other
expression_of_self-renewal-related_genes	Other
isolation	Other
ALDH	Other
isolation	Other
cancer_prevention	Disease
novel_utilization_of_3-O-p-coumaroyltormentic_acid_for_breast_cancer_therapy_via_disruption	Disease
isolation_of_one_compound	Other
isolation_of_one_compound	Other
isolation	Other
isolation_of_one_compound	Other
breast_cancer_cell_proliferation	Disease
phytochemicals	Other
early-stage_breast_cancer	Disease
end_of_RT_treatment_skin_toxicity	Disease
end	Other
15_fractions	Other
patients	Species
association_of_chemotherapy_with_boost	Other
association_with_boost	Other
terms_of_acute	Other
excellent/good	Other
association_of_chemotherapy	Other
whole_breast	Other
excellent/good	Other
excellent/good	Other
results_of_other_studies_published_on_association_of_hypofractionation	Other
51.1_%_of_patients_G2	Species
association_with_boost	Other
excellent/good	Other
terms	Other
15_fractions_for_total_dose	Other
terms_of_acute	Other
association_of_chemotherapy	Other
breast_cancer	Disease
terms_of_acute	Other
phase_II_trial	Other
VMAT-SIB_technique	Other
breast	Other
association_of_chemotherapy_with_boost	Other
15_fractions_for_dose	Other
recurrence_selection_tools	Other
recurrence_risk_beyond_5_years	Other
late_recurrence_selection_tools	Other
ER-positive/human_epidermal_growth_factor_receptor_2-negative_breast_cancer	Disease
recurrence_selection_tools	Other
treatment_cessation	Other
patient_selection	Species
recurrence_risk_beyond_5_years_after_diagnosis	Other
late_recurrence_selection_tools	Other
late_recurrence_selection_tools	Other
recurrence_risk	Other
late_recurrence_selection_tools	Other
high_expression_of_estrogen-responsive_genes	Other
recurrences	Other
recurrence_selection_tools	Other
recurrence_selection_tools	Other
high_recurrence_risk_beyond_5_years_after_diagnosis	Other
high_recurrence_risk_beyond_5_years	Other
recurrence_risk_beyond_5_years	Other
5_years_of_tamoxifen_therapy_with_5_years_of_tamoxifen	Chemical	Chemical
benefit	Other
genes	Other
benefit	Other
recurrence_selection_tools	Other
5_years_of_endocrine_therapy_reduced	Other
late_recurrence_selection_tools	Other
late_recurrences_in_patients_with_tumors	Species	Disease
extended_endocrine_therapy	Other
late_recurrences_in_patients	Species
recurrences_occurring	Other
benefit_from_extended_endocrine_therapy	Other
late_recurrence_selection_tools	Other
recurrences_in_patients	Species
setting	Other
estrogen-responsive_genes	Other
genes	Other
high_recurrence_risk	Other
recurrences_in_patients_with_tumors	Species	Disease
estrogen_receptor	Chemical
recurrences_in_patients_with_tumors	Species	Disease
recurrences	Other
recurrences	Other
recurrences_in_patients	Species
benefit_from_extended_endocrine_therapy	Other
genes	Other
setting	Other
high_recurrence_risk_beyond_5_years	Other
high_recurrence_risk	Other
patients_with_tumors_showing	Species	Disease
late_recurrences_in_patients_with_tumors	Species	Disease
recurrences	Other
late_recurrences_in_patients	Species
late_recurrences	Other
recurrence_risk	Other
late_recurrences	Other
pathway	Other
benefit_from_endocrine_therapy	Other
recurrence_risk_beyond_5_years_after_diagnosis	Other
high_recurrence_risk_beyond_5_years_after_diagnosis	Other
recurrences	Other
late_recurrences	Other
recurrences_occurring	Other
tumors_showing	Disease
recurrence_selection_tools	Other
estrogen-responsive_genes	Other
recurrences_occurring	Other
benefit_from_endocrine_therapy	Other
continue	Other
HR_positive_breast_cancer_PI3K_inhibitors	Gene	Disease
sequencing	Other
initiation_are_lacking	Other
ET	Other
development_of_generation_of_targeted_therapies_for_advanced_breast_cancer	Disease
development_of_new_generation_of_targeted_therapies_for_advanced_breast_cancer	Disease
progression_free_survival	Other
potential_biomarkers_of_resistance	Other
mechanisms	Other
patients_with_hormone_receptor	Species
initiation_of_chemotherapy_long_term_overall_survival_data_are_lacking	Other
continue	Other
potential_biomarkers_of_resistance	Other
selective_estrogen_receptor_modulators	Chemical
unclear	Other
patients	Species
backbone_in_cases	Other
hormone_receptor	Other
ideal_strategy	Other
treatment_of_advanced_HR_positive_HER2_negative_breast_cancer_highlighting	Gene	Gene	Disease
initiation_of_chemotherapy_term_survival_data_are_lacking	Other
growth_pathway	Other
cyclin_dependent_kinase	Other
initiation_of_chemotherapy_long_term_survival_data_are_lacking	Other
initiation_of_chemotherapy_long_term_overall_survival_data_are_lacking	Other
progression_free_survival	Other
potential_biomarkers	Other
strategy	Other
less_toxicity	Disease
supportive_care_allowing	Other
progression_survival	Other
backbone_of_treatment	Other
ideal_strategy	Other
initiation_are_lacking	Other
HR_positive_metastatic_breast_cancer	Gene	Disease
outcomes	Other
supportive_care	Other
backbone_of_treatment_in_cases	Other
growth_pathway_in_HR_positive_breast_cancer_PI3K_inhibitors	Gene	Disease
treatment	Other
patients_with_hormone_receptor	Species
mechanisms	Other
clinic	Other
progression_survival	Other
potential_biomarkers	Other
initiation_of_chemotherapy_term_survival_data_are_lacking	Other
effectiveness	Other
women_with_breast_cancer	Species	Disease
dysfunctional_excitement	Other
Â±_standard_deviation_SD	Other
women	Species
penetration_pain	Disease
penetration_pain_desire_lubrication	Disease
46.34_Â±_8.28_years	Other
cancer	Disease
penetration_pain	Disease
Women_'s_Sexual_Function	Species
514_women_with_breast_cancer	Species	Disease
dysfunctional_excitement	Other
sexuality	Other
breast_cancer	Disease
breast_cancer	Disease
excitement	Other
514_women	Species
increase_in_ERÎ±_protein_levels	Other
ERÎ±_degradation	Other
related_to_endocrine_therapy_resistance	Other
development_of_tumors	Disease
related	Other
coregulators_of_specific_protein_complexes	Other
coactivators	Other
endocrine_therapy_resistance	Other
progression_of_breast_cancer	Disease
related	Other
endocrine_therapy_resistance	Other
ERÎ±_transcription_cycle	Other
coactivators_for_ERÎ±	Other
development_of_mammary_tumors	Disease
coactivators	Other
ubiquitin_proteasome_system	Other
ERÎ±_transcription_cycle	Other
ERÎ±_protein_levels	Other
related_to_therapy_resistance	Other
development	Other
coactivators_for_ERÎ±	Other
related_to_therapy_resistance	Other
ERÎ±_degradation	Other
development_of_mammary_tumors	Disease
estradiol_hormone	Other
development	Other
therapy_resistance	Other
ubiquitin_proteasome_system	Other
related_to_endocrine_therapy_resistance	Other
ERÎ±	Other
OBCS	Other
investigation	Other
Objective_Breast_Cosmesis_Scale	Other
adjuvant_partial_breast_irradiation	Other
further_investigation	Other
breast_irradiation	Other
patient	Species
partial_breast_irradiation	Other
further_investigation_in_future_studies	Other
investigation_in_future_studies	Other
changes	Other
nonstandardized_photographs	Other
breast-conserving_surgery	Other
adjuvant_breast_irradiation	Other
further_investigation	Other
accelerated_partial_breast_irradiation	Other
patient	Species
adjuvant_accelerated_breast_irradiation	Other
breast_cosmesis	Other
investigation	Other
trainees	Other
surgery	Other
changes_in_breast_cosmesis	Other
treatment	Other
treatment	Other
further_investigation_in_future_studies	Other
adjuvant_accelerated_partial_breast_irradiation	Other
interstitial_fractionated_high-dose-rate_brachytherapy	Other
brachytherapy	Other
future_studies	Other
nanomolar_dose	Other
distinct_antagonism	Other
MTT	Chemical
continued_presence	Other
aspects_of_malignant_phenotype	Other
several_aspects	Other
pivotal_role_of_IR_antagonist_S961	Chemical
even_presence_of_insulin	Gene
role_of_IR_antagonist_S961	Chemical
role_of_IR_antagonist_S961_on_IR_signalling_in_MCF-7_MDA-MB-231	Chemical
presence_of_S961	Chemical
proliferation_in_breast_tumour_cells	Other
role_on_IR_signalling_in_MCF-7_MDA-MB-231	Other
role_on_IR_signalling	Other
pivotal_role_of_IR_antagonist_S961_on_IR_signalling	Chemical
IR-A_isoform	Other
breast_carcinoma_cells	Other
several_aspects_of_malignant_phenotype_including_cell_proliferation	Other
IR-A_isoform	Other
expression_of_IRs	Other
role_of_IR_antagonist_S961_on_IR_signalling	Chemical
continued_presence_of_S961	Chemical
breast_cancer_pathogenesis	Disease
several_aspects_of_malignant_phenotype_including_cell_proliferation	Other
pivotal_role_on_IR_signalling	Other
breast_cancer_pathogenesis	Disease
IRs	Other
cellular_proliferation_in_breast_tumour_cells	Other
proliferation_owing	Other
several_aspects_of_malignant_phenotype	Other
growth	Other
quantitative_PCR	Other
presence_of_S961	Chemical
aspects_of_phenotype_including_cell_proliferation	Other
breast_tumour_cells	Other
IRs	Other
IR_overexpression	Other
continued_presence_of_S961	Chemical
antagonism	Other
expression_of_IRs	Other
IRs	Other
several_aspects_of_phenotype_including_cell_proliferation	Other
pivotal_role_on_IR_signalling_in_MCF-7_MDA-MB-231	Other
breast_cancer_pathogenesis	Disease
extensive_growth	Other
aspects_of_malignant_phenotype_including_cell_proliferation	Other
pivotal_role_of_IR_antagonist_S961_on_IR_signalling_in_MCF-7_MDA-MB-231	Chemical
presence	Other
cellular_proliferation_in_breast_tumour_cells	Other
several_aspects_of_phenotype	Other
MCF-7_MDA-MB-231	Other
continued_presence	Other
IR_overexpression	Other
study_2	Other
approximately_3_years	Other
decline	Other
Pearson_'s_correlation_coefficient	Other
cognitive_decline	Other
WMS-R_indices_between_two_studies	Other
plasma_IL-6_levels	Gene
breast_cancer_patients	Disease	Species
unclear	Other
breast_conservation_therapy	Other
study_2	Other
study_2	Other
approximately_3_years	Other
study_2	Other
three_different_metrics_of_mortality	Other
NF-ÎºB/SOX4_activation	Other
mouse	Species
reduction_in_breast_cancer_growth	Disease
investigation	Other
breast_cancer_growth	Disease
investigation	Other
responsive_gene	Other
highest_responsive_gene	Other
CXCL1_administration	Gene
further_investigation	Other
investigation	Other
reduction	Other
highest_responsive_gene	Other
loop_TAMs	Other
breast_cancer_lymph_node_metastasis	Disease	Disease
breast_cancer_metastasis	Disease	Disease
CXCL1_administration	Gene
investigation	Other
highest_gene	Other
investigation	Other
gene	Other
loop	Other
investigation	Other
significant_reduction_in_breast_cancer_growth	Disease
investigation	Other
further_investigation	Other
its_transcription	Other
further_investigation	Other
further_investigation	Other
SOX4_promoter	Gene
further_investigation	Other
responsive_gene	Other
breast_cancer_lymph_node_metastasis	Disease	Disease
further_investigation	Other
further_investigation	Other
TAMs	Other
loop_TAMs	Other
breast_cancer_lymph_node_metastasis	Disease	Disease
highest_gene	Other
breast_cancer_lymph_node_metastasis	Disease	Disease
investigation	Other
Level_0_doses	Other
Level_1_doses	Other
Grade_3_oral_mucositis	Other
advanced_recurrent_breast_cancer	Disease
Level_1_doses	Other
GEM	Chemical
combination_with_other_chemotherapeutic_agents	Other
Level_0_doses	Other
Grade_3_oral_mucositis	Other
Level_1	Other
Level_0	Other
ERI	Other
only_1_patient_of_Level_1_group	Species
metastatic_breast_cancer	Disease
ERI	Other
Japanese_patients_with_metastatic_breast_cancer	Species	Disease
Level_1_doses	Other
closed_loop_structure	Other
cancer-related_death	Disease
